TMPRSS2: Potential Biomarker for COVID‐19 Outcomes

Author:

Strope Jonathan D.1,PharmD Cindy H. Chau,1,Figg William D.1

Affiliation:

1. Genitourinary Malignancies BranchCenter for Cancer ResearchNational Cancer InstituteNational Institutes of Health Bethesda Maryland USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference41 articles.

1. Garg SKL WhitakerM et al.Hospitalization rates and characteristics of patients hospitalized with laboratory‐confirmed coronavirus disease 2019 — COVID‐NET 14 States March 1‐30 2020. Atlanta GA: Centers for Disease Control and Prevention; April 8 2020.

2. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

3. ACE2 Gene Polymorphisms Do Not Affect Outcome of Severe Acute Respiratory Syndrome

4. Asians and other races express similar levels of and share the same genetic polymorphisms of the SARS‐CoV‐2 cell‐entry receptor;Chen Y;Preprints

5. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID‐19 severity in Italy;Asselta R, Mantovani A, Duga S;Medrxiv Preprint

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3